| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/16/2003 | WO2003004706A1 Glucocorticoid-induced receptor and methods of use |
| 01/16/2003 | WO2003004704A2 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity |
| 01/16/2003 | WO2003004703A1 Process for producing template dna and process for producing protein in cell-free protein synthesis system with the use of the same |
| 01/16/2003 | WO2003004702A2 Method for determining chromatin structure |
| 01/16/2003 | WO2003004701A2 Method for determining the capacity of fusarium in producing trichothecene toxins |
| 01/16/2003 | WO2003004700A1 Method and system for detecting inter-chromosomal imbalance by fluorescent in situ hybridization (fish) on interphase nuclei |
| 01/16/2003 | WO2003004699A2 Method for identifying nucleic acid molecules amplified in a polymerase chain reaction |
| 01/16/2003 | WO2003004698A2 Method for monitoring and modulating protein folding |
| 01/16/2003 | WO2003004697A2 Method for detecting mutagenic substances |
| 01/16/2003 | WO2003004696A2 A distributed system for epigenetic based prediction of complex phenotypes |
| 01/16/2003 | WO2003004695A1 Methods for identifying agents that modulate diacylglycerol kinase delta (dgk&) alktivity |
| 01/16/2003 | WO2003004694A1 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 01/16/2003 | WO2003004693A2 Methods and compositions for modulating adenosine triphosphate (atp) in cells and preventing cell injury or death via post-translational modifications to atp synthase |
| 01/16/2003 | WO2003004692A2 Screening processes for agents modulating cholesterol levels |
| 01/16/2003 | WO2003004691A2 Regulators of biofilm formation and uses thereof |
| 01/16/2003 | WO2003004690A2 Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| 01/16/2003 | WO2003004689A2 Regulators of biofilm formation and uses thereof |
| 01/16/2003 | WO2003004688A2 Method of genomic analysis |
| 01/16/2003 | WO2003004686A2 Fluorescence-based assay for the detection of specific nucleic acids using photon counting |
| 01/16/2003 | WO2003004680A2 Atherosclerosis susceptibility gene locus 1 (athsq1) and 2 (athsq2) |
| 01/16/2003 | WO2003004677A2 Methods for generating differential profiles by combining data obtained in separate measurements |
| 01/16/2003 | WO2003004645A1 Diagnosis and treatment of cancer involving the notch pathway |
| 01/16/2003 | WO2003004644A1 Delivery of dsrna to arthropods |
| 01/16/2003 | WO2003004642A1 Method of amplifying noncyclic nucleic acid fragment |
| 01/16/2003 | WO2003004640A1 Dna arrays for measuring sensitivity to anticancer agent |
| 01/16/2003 | WO2003004638A1 Method of judging risk of side effects of remedy for rheumatoid arthritis (ra) |
| 01/16/2003 | WO2003004630A2 Method for determining the genetic predisposition of a mammal for its milk fat content and/or for its intramuscular fat content |
| 01/16/2003 | WO2003004627A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | WO2003004621A2 Sir2 activity |
| 01/16/2003 | WO2003004615A2 Secreted proteins |
| 01/16/2003 | WO2003004614A2 Identification and use of conserved noncoding sequences |
| 01/16/2003 | WO2003004613A2 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | WO2003004611A2 Human olfactory nucleotide-gated ion channels |
| 01/16/2003 | WO2003004608A2 Drug metabolizing enzymes |
| 01/16/2003 | WO2003004607A2 Aggrecanase molecules |
| 01/16/2003 | WO2003004605A2 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 01/16/2003 | WO2003004604A2 Phage displayed pdz domain ligands |
| 01/16/2003 | WO2003004569A1 Method for increasing hydrophilicity of fluorescent label compounds |
| 01/16/2003 | WO2003004532A2 Q9ul33/q9nzz4 and q9h5p3 splice variants |
| 01/16/2003 | WO2003004520A2 Mycobacterial antigens expressed during latency |
| 01/16/2003 | WO2003004516A1 Novel chromogenic substances and use thereof for the determination of carboxypeptidase activities |
| 01/16/2003 | WO2003004462A1 Catalase-inactivating compounds and the use thereof |
| 01/16/2003 | WO2003004275A1 Droplet dispensing system |
| 01/16/2003 | WO2003004057A1 Ephrin and eph receptor mediated immune modulation |
| 01/16/2003 | WO2003004050A1 Methylation of histone h4 at arginine 3 |
| 01/16/2003 | WO2003003979A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | WO2003003906A2 Diagnostic and screening methods for bladder cancer |
| 01/16/2003 | WO2003003904A2 Coactivators in the diagnosis and treatment of breast cancer |
| 01/16/2003 | WO2003003824A1 Potential-dependent ca2+ channel a1b knockout non-human animal |
| 01/16/2003 | WO2003003810A2 Methods for detection and quantification of analytes in complex mixtures |
| 01/16/2003 | WO2002094194A3 Compositions and methods for inhibiting metastasis |
| 01/16/2003 | WO2002059343A3 Biological markers and diagnostic tests for angiotensin converting enzyme inhibitor- and vasopeptidase inhibitor-associated angioedema |
| 01/16/2003 | WO2002059148A8 A method for identification, isolation and production of antigens to a specific pathogen |
| 01/16/2003 | WO2002059147A3 Activatable cytolytic or drug delivery peptides and uses thereof |
| 01/16/2003 | WO2002053724A3 Enzymatic deprotection of amines and hydroxides |
| 01/16/2003 | WO2002053712A3 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 01/16/2003 | WO2002052038A3 Method for normalizing the relative intensities of detection signals in hybridization arrays |
| 01/16/2003 | WO2002049761A3 Automated laboratory system and method |
| 01/16/2003 | WO2002046387A3 Plant derived hydroxy phenyl pyruvate dioxygenases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases |
| 01/16/2003 | WO2002046223A3 Compositions and methods related to the minn1 tumor suppressor gene and protein |
| 01/16/2003 | WO2002042445A3 Differentiated cells suitable for human therapy |
| 01/16/2003 | WO2002041906A3 Methods and apparatus for producing gender enriched sperm |
| 01/16/2003 | WO2002040540A3 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 01/16/2003 | WO2002033044A3 Methods of high-throughput screening for internalizing antibodies |
| 01/16/2003 | WO2002032286A3 Protein-protein interactions in neurodegenerative diseases |
| 01/16/2003 | WO2002031109A3 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 01/16/2003 | WO2002030944A3 Fluorescent nucleobase conjugates having anionic linkers |
| 01/16/2003 | WO2002030266A3 Detection of dna damage |
| 01/16/2003 | WO2002029412A3 Selective binding materials |
| 01/16/2003 | WO2002027017A3 Method for quantifying phosphokinase activity on proteins |
| 01/16/2003 | WO2002027016A3 Gene involved in dietary sterol absorption and excretion and uses therefor |
| 01/16/2003 | WO2002026195A3 Oncology tissue microarrays |
| 01/16/2003 | WO2002022862A3 Methods for identifying modulators of protein interactions |
| 01/16/2003 | WO2002022806A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 01/16/2003 | WO2002021132A3 Cell assays |
| 01/16/2003 | WO2002020179A3 Modified carbon, silicon and germanium surfaces |
| 01/16/2003 | WO2002018644A3 Mass spectrometric analysis of biopolymers |
| 01/16/2003 | WO2002016595A3 Kidney-specific protein |
| 01/16/2003 | WO2002016587A3 Microtubule-associated proteins and tubulins |
| 01/16/2003 | WO2002002772A3 Human extracellular matrix (ecm)-related tumor marker |
| 01/16/2003 | WO2001098323A8 G-protein coupled receptors |
| 01/16/2003 | WO2001094584A3 21784, a novel human calcium channel family member and uses thereof |
| 01/16/2003 | WO2001092549A3 Method and composition for targeting an adenoviral vector |
| 01/16/2003 | WO2001092490A3 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 01/16/2003 | WO2001090156A3 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/16/2003 | WO2001087937A3 G-protein coupled receptors |
| 01/16/2003 | WO2001085941A9 Myc targets |
| 01/16/2003 | WO2001081542A9 Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data |
| 01/16/2003 | WO2001081375A9 Dna & protein binding miniature proteins |
| 01/16/2003 | WO2001080721A9 Methods and compositions for the diagnosis of schizophrenia |
| 01/16/2003 | WO2001079538A3 Cell-binding nucleic acid molecules (aptamers) |
| 01/16/2003 | WO2001075162A3 Microarrays to screen regulatory genes |
| 01/16/2003 | WO2001075159A3 Microchip arrays of regulatory genes |
| 01/16/2003 | WO2001073135A3 Approaches for hpv detection and staging by targeting the e6 gene region of the viral genome |
| 01/16/2003 | WO2001073134A3 Gene profiling arrays |
| 01/16/2003 | WO2001071009A3 Whole-body optical imaging of gene expression and uses thereof |
| 01/16/2003 | WO2001070174A8 Vegf-modulated genes and methods employing them |
| 01/16/2003 | WO2001068880A9 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 01/16/2003 | WO2001068805A9 Human olfactory receptors and genes encoding same |
| 01/16/2003 | WO2001064944A9 MODULATION OF PLEIOTROPHIN SIGNALING BY RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE β/$g(z) |